|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 25/24 | (2006.01) |
| A61K 31/451 | (2006.01) | ||
| C07D 211/22 | (2006.01) |
| (11) | Number of the document | 3962601 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20808308.9 |
| Date of filing the European patent application | 2020-11-06 | |
| (97) | Date of publication of the European application | 2022-03-09 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-31 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (86) | Number | PCT/EP2020/081357 |
| Date | 2020-11-06 |
| (87) | Number | WO 2021/089824 |
| Date | 2021-05-14 |
| (30) | Number | Date | Country code |
| 19207578 | 2019-11-07 | EP | |
| 202017090457 | 2020-11-05 | US |
| (72) |
KRISTENSEN, Jesper Langgaard , DK
JENSEN, Anders Asbjørn , DK
MÄRCHER-RØRSTED, Emil , DK
LETH-PETERSEN, Sebastian , DK
|
| (73) |
Lophora ApS ,
Gyldenlundsvej 21, 1., 2920 Charlottenlund,
DK
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 5-HT2A agonistai, skirti panaudoti depresijos gydymui |
| 5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION |
| Payment date | Validity (years) | Amount | |
| 2025-10-20 | 6 | 139.00 EUR |
| 2026-11-06 |